Cullen Capital Management LLC Sells 6,194 Shares of Oracle Corporation $ORCL

Oracle logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Cullen Capital Management cut its Oracle stake by 27.2%, selling 6,194 shares in the third quarter; it retained 16,547 shares valued at about $2.27 million.
  • Institutional investors own 42.44% of Oracle shares. Insider activity was mixed: insiders sold 36,075 shares worth about $5.34 million over 90 days, while a director purchased 25,000 shares.
  • Oracle beat quarterly earnings and revenue estimates, with revenue up 29.6% year over year. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $249.27.
  • MarketBeat previews top five stocks to own in December.

Cullen Capital Management LLC reduced its position in Oracle Corporation (NYSE:ORCL - Free Report) by 27.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,547 shares of the enterprise software provider's stock after selling 6,194 shares during the quarter. Cullen Capital Management LLC's holdings in Oracle were worth $2,272,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in ORCL. Bank of New York Mellon Corp bought a new position in Oracle during the 2nd quarter worth about $1,911,930,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Oracle during the 2nd quarter valued at about $625,454,000. Corient Private Wealth LP bought a new stake in shares of Oracle in the 2nd quarter valued at about $186,175,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Oracle in the 3rd quarter valued at about $96,746,000. Finally, First Trust Advisors LP raised its holdings in shares of Oracle by 23.3% in the 1st quarter. First Trust Advisors LP now owns 3,633,070 shares of the enterprise software provider's stock valued at $534,461,000 after purchasing an additional 685,570 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Insider Activity at Oracle

In other Oracle news, EVP Maria Smith sold 2,631 shares of Oracle stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the transaction, the executive vice president directly owned 64,357 shares of the company's stock, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen H. Rusckowski purchased 25,000 shares of Oracle stock in a transaction dated Tuesday, September 29th. The shares were acquired at an average cost of $139.35 per share, for a total transaction of $3,483,750.00. Following the completion of the transaction, the director owned 25,390 shares of the company's stock, valued at approximately $3,538,096.50. This represents a 6,410.26% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders sold 36,075 shares of company stock valued at $5,342,123 over the last 90 days. Insiders own 38.40% of the company's stock.

Trending Headlines about Oracle

Here are a few of the latest headlines about ORCL:

  • Positive Sentiment: Oracle Health said the U.S. Department of Veterans Affairs and Department of War joined its federally designated health-information exchange network, expanding its reach among government and community clinicians. Oracle federal health data exchange
  • Positive Sentiment: Shore Medical Center and Shore Physicians Group selected Oracle Health’s AI-powered electronic health record system, adding a customer win in healthcare technology. Shore selects Oracle Health EHR
  • Positive Sentiment: A report said Appaloosa added Oracle shares in the third quarter, a potentially supportive signal from the hedge fund, though the position reflects an earlier period. Appaloosa portfolio moves

Oracle Stock Performance

Shares of Oracle stock opened at $118.94 on Tuesday. The company has a market capitalization of $359.63 billion, a PE ratio of 18.64, a P/E/G ratio of 0.89 and a beta of 1.79. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.17 and a current ratio of 1.17. The company has a 50-day simple moving average of $135.86 and a two-hundred day simple moving average of $153.80. Oracle Corporation has a one year low of $109.21 and a one year high of $250.25.

Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating the consensus estimate of $1.74 by $0.18. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The business had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. During the same period in the prior year, the firm posted $1.47 earnings per share. The company's quarterly revenue was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Research analysts expect that Oracle Corporation will post 6.71 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 23rd. Investors of record on Friday, October 9th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. Oracle's dividend payout ratio is presently 31.35%.

Wall Street Analysts Forecast Growth

ORCL has been the subject of several research reports. Royal Bank Of Canada lowered their price target on shares of Oracle from $190.00 to $165.00 and set a "sector perform" rating for the company in a research report on Friday, September 11th. Cantor Fitzgerald reissued an "overweight" rating and set a $284.00 price objective on shares of Oracle in a report on Thursday, October 22nd. Guggenheim reissued a "buy" rating on shares of Oracle in a research note on Thursday, October 29th. Freedom Broker lowered their target price on Oracle from $210.00 to $205.00 and set a "buy" rating for the company in a report on Monday, September 14th. Finally, BTIG Research assumed coverage on Oracle in a report on Monday, November 2nd. They set a "buy" rating for the company. One analyst has rated the stock with a Strong Buy rating, thirty-seven have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Oracle has an average rating of "Moderate Buy" and a consensus target price of $249.27.

Check Out Our Latest Analysis on Oracle

About Oracle

(Free Report)

Oracle Corporation is a technology company that develops and provides database software, cloud services, and enterprise applications. Its products help organizations manage data, run business operations, and build and deploy applications. Oracle's offerings include Oracle Database, Oracle Cloud Infrastructure, and cloud-based applications for functions such as finance, human resources, supply chain management, and customer experience. The company also provides software support, consulting, and related services.

Featured Articles

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines